$53.54 -0.25 (%) Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- - New York Stock Exchange, Inc.

May. 5, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga | Feb. 8, 2016 | 09:38AM EST
  2. Worst Performing Industries For February 4, 2016

    Benzinga | Feb. 4, 2016 | 11:37AM EST
  3. The 2016 Nintai Charitable Trust Portfolio: Annual Review

    GuruFocus | Jan. 18, 2016 | 15:36PM EST
  4. Novo Nordisk Files for Regulatory Approval Of Long-Acting Factor IX in EU for Treatment of Haemophilia B

    Benzinga | Jan. 7, 2016 | 05:58AM EST
  5. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  6. Novo Nordisk Fourth Phase 3a Trial with Semaglutide in People with Type 2 Diabetes Shows Drug Safe, Well-Tolerated

    Benzinga | Dec. 17, 2015 | 04:37AM EST
  7. Jim Simons' Top Holdings Include VeriSign, Chipotle

    GuruFocus | Dec. 15, 2015 | 17:42PM EST
  8. Novo Nordisk Submits NDA to FDA for Faster-Acting Insulin Aspart for Treatment of Type 1, 2 Diabetes

    Benzinga | Dec. 9, 2015 | 04:19AM EST
  9. Amazon, Alibaba, Facebook: A Top Mutual Fund's Bets

    IBD | Dec. 2, 2015 | 18:16PM EST
  10. Ablynx Announces Nanobody Drug Discovery Collaboration, Licence Agreement With Novo Nordisk

    Benzinga | Nov. 25, 2015 | 04:23AM EST
  11. Vestas, Novo Lead As Denmark Stocks Outpace Peers

    IBD | Nov. 19, 2015 | 17:44PM EST
  12. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
  13. Diabetes hits drugmakers

    IBD | Oct. 29, 2015 | 18:51PM EST
  14. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD | Oct. 29, 2015 | 12:40PM EST
  15. Jim Simons' Five Most-Heavily Weighted Holdings

    GuruFocus | Oct. 21, 2015 | 19:04PM EST
  16. Ken Fisher Reduces Stake in Toyota, Increases Position in Anheuser-Busch

    GuruFocus | Oct. 20, 2015 | 18:51PM EST
  17. Emisphere Signs License Agreement With Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications and Amends GLP-1 Agreement

    Benzinga | Oct. 15, 2015 | 08:26AM EST
  18. Warren Buffett Not Top 100 CEO; Ex VW CEO Is No. 20

    IBD | Oct. 12, 2015 | 13:33PM EST
  19. Novo Nordisk Says Second Phase 3A Trial With Semaglutide in People With Type 2 Diabetes Achieved Objective

    Benzinga | Sep. 25, 2015 | 04:19AM EST
  20. Jim Simons and Ken Fisher Decrease Exposure on Novo Nordisk A/S

    GuruFocus | Sep. 14, 2015 | 12:50PM EST
  21. Benzinga's Top Initiations

    Benzinga | Aug. 28, 2015 | 09:33AM EST
  22. US Stock Futures Slip Ahead Of Economic Data

    Benzinga | Aug. 14, 2015 | 07:11AM EST
  23. Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology

    Benzinga | Aug. 14, 2015 | 06:39AM EST
  24. More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range

    IBD | Aug. 3, 2015 | 18:21PM EST
  25. Six International Leaders Preparing To Report Results

    IBD | Jul. 30, 2015 | 18:23PM EST
  26. Nintai Returns: Q2 2015

    GuruFocus | Jul. 1, 2015 | 13:11PM EST
  27. Top Europe Stocks Rally On Greece Bailout Hopes

    IBD | Jun. 22, 2015 | 15:17PM EST
  28. Jim Simons' Top 3 Positions and One That Doubled Return

    GuruFocus | Jun. 10, 2015 | 16:33PM EST
  29. Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE

    GuruFocus | May. 3, 2015 | 23:28PM EST
  30. Gilead's Strong Profit Tops Mixed Drug maker Reports

    IBD | Apr. 30, 2015 | 18:50PM EST
  31. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 10:48AM EST
  32. Novo Nordisk Posts Rise In Profit

    Benzinga | Apr. 30, 2015 | 06:06AM EST
  33. MannKind Looks Good For Long Term Investors

    GuruFocus | Apr. 29, 2015 | 12:37PM EST
  34. Novo Nordisk Will Repurchase Shares

    Benzinga | Apr. 22, 2015 | 08:35AM EST
  35. Successful diabetes drug trial

    IBD | Feb. 20, 2015 | 18:40PM EST
  36. Novo Nordisk Pops On Successful Diabetes Drug Trial

    IBD | Feb. 20, 2015 | 11:42AM EST
  37. Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher

    Benzinga | Feb. 20, 2015 | 11:14AM EST
  38. Morning Market Gainers

    Benzinga | Feb. 20, 2015 | 09:46AM EST
  39. Friday #PreMarket Movers: Arista Networks Up, CollabRx Down

    Benzinga | Feb. 20, 2015 | 09:00AM EST
  40. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 20, 2015 | 08:15AM EST
  41. To Reinvest or Not Reinvest: That is the Question

    GuruFocus | Feb. 19, 2015 | 09:55AM EST
  42. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  43. Guru Stocks at 52-Week Lows: BABA, NVO, PCLN, ING, EMR

    GuruFocus | Feb. 9, 2015 | 11:38AM EST
  44. Novo Nordisk Posts Higher Profit

    Benzinga | Jan. 30, 2015 | 05:06AM EST
  45. Earnings Scheduled For January 30, 2015

    Benzinga | Jan. 30, 2015 | 04:57AM EST
  46. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  47. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  48. FDA's OKs may prescribe hits

    IBD | Dec. 26, 2014 | 18:49PM EST
  49. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  50. How To Profit From The Obesity Epidemic

    Benzinga | Dec. 8, 2014 | 16:54PM EST
Trading Center